Product
HRS5091
1 clinical trial
1 indication
Indication
Chronic Hepatitis BClinical trial
A Single-center, Single-arm, Open-label, Fixed-sequence, Self-controlled Study of the Effects of HRS5091 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin and Rosuvastatin in Healthy VolunteersStatus: Completed, Estimated PCD: 2022-06-23